Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Taste disorder, Tremor
Clinical narrative: Even cannot taste at all; Food tastes terrible; shaking/in a terrible shape with 3 blankets wrapped around him; chills; Joints ache; a headache is starting; sore arm; swelling in the arm; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Even cannot taste at all), TASTE DISORDER (Food tastes terrible), TREMOR (shaking/in a terrible shape with 3 blankets wrapped around him), PAIN IN EXTREMITY (sore arm) and PERIPHERAL SWELLING (swelling in the arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 044B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included TROSPIUM for Anxiety, PANTOPRAZOLE SODIUM, ATORVASTATIN and VITAMINS NOS for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PERIPHERAL SWELLING (swelling in the arm). On 18-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced AGEUSIA (Even cannot taste at all), TASTE DISORDER (Food tastes terrible), TREMOR (shaking/in a terrible shape with 3 blankets wrapped around him), CHILLS (chills), ARTHRALGIA (Joints ache) and HEADACHE (a headache is starting). At the time of the report, AGEUSIA (Even cannot taste at all), TASTE DISORDER (Food tastes terrible), TREMOR (shaking/in a terrible shape with 3 blankets wrapped around him), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swelling in the arm), ARTHRALGIA (Joints ache) and HEADACHE (a headache is starting) outcome was unknown and CHILLS (chills) had not resolved.            No treatment medication was reported.  Company Comment : This spontaneous case concerns a 60 year old male with no medical history reported, vaccinated with mRNA-1273 vaccine as primary series for Covid 19 for two doses. who experienced non-serious , unexpected . AESI event of ageusia and other non-serious , unexpected events of  taste disorder , tremor and non-serious , expected events of chills , headache and arthralgia which occurred the day after the vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) .  On an unknown date  after the vaccination with the 3rd dose , he experienced  non-serious , unexpected events of peripheral swelling  and pain in extremity . The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be given and also events' outcome were unknown or unresolved. But it is noted that for the event pain extremity it is positive re-challenge since this event was reported as recurring after each dose. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.   This case was linked to MOD-2021-416959, MOD-2021-416968 (Patient Link).; Sender's Comments: This spontaneous case concerns a 60 year old male with no medical history reported, vaccinated with mRNA-1273 vaccine as primary series for Covid 19 for two doses. who experienced non-serious , unexpected . AESI event of ageusia and other non-serious , unexpected events of  taste disorder , tremor and non-serious , expected events of chills , headache and arthralgia which occurred the day after the vaccination with the 3rd dose of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) .  On an unknown date  after the vaccination with the 3rd dose , he experienced  non-serious , unexpected events of peripheral swelling  and pain in extremity . The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be given and also events' outcome were unknown or unresolved. But it is noted that for the event pain extremity it is positive re-challenge since this event was reported as recurring after each dose. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.